Author

Ranjan Kumar Sur

Observed names: R K Sur, R Sur, R. K. Sur, R. SUR, R. Sur, R.K. Sur, Ranjan K Sur, Ranjan K. Sur, Ranjan Sur, Sur, Ranjan K.

Observed institutions: University of British Columbia, University of the Witwatersrand, Juravinski Cancer Centre, Johannesburg Hospital, Juravinski Hospital, Medwin Hospital, South African Institute for Medical Research, University of British Columbia, Okanagan Campus, Post Graduate Institute of Medical Education and Research, Hamilton Health Sciences, McMaster University

ORCID: 0000-0003-4937-5877

Observed ORCID: 0000-0003-4937-5877

OpenAlex ID: A5087816082

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

2006 · James A. Bonner, Paul M. Harari, et al. · New England Journal of Medicine · 5,120

PDF

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

2009 · James A Bonner, Paul M Harari, et al. · The Lancet Oncology · 1,982

Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline

2011 · George Rodrigues, Gregory M.M. Videtic, et al. · Practical Radiation Oncology · 214

The spectrum of HIV-1 related cancers in South Africa

2000 · Freddy Sitas, Rosana Pacella-Norman, et al. · International Journal of Cancer · 170

Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial

2008 · Minesh P. Mehta, William R. Shapiro, et al. · International Journal of Radiation Oncology*Biology*Physics · 164

Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—an International Atomic Energy Agency study

2002 · Ranjan K Sur, C.Victor Levin, et al. · International Journal of Radiation Oncology*Biology*Physics · 149

Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans

2002 · R Pacella-Norman, M I Urban, et al. · British Journal of Cancer · 129

PDF

Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer

1998 · Ranjan K. Sur, Bernard Donde, et al. · International Journal of Radiation Oncology*Biology*Physics · 127

Adenoid Cystic Carcinoma of the Salivary Glands: A Review of 10 Years

1997 · Ranjan K. Sur, Bernard Donde, et al. · The Laryngoscope · 123

Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency

2010 · Eduardo Rosenblatt, Glenn Jones, et al. · Radiotherapy and Oncology · 101

Radiation therapy of esophageal cancer: Role of high dose rate brachytherapy

1992 · Ranjan K. Sur, Deepinder P. Singh, et al. · International Journal of Radiation Oncology*Biology*Physics · 89

Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer

2004 · Ranjan Sur, Bernard Donde, et al. · Brachytherapy · 65

Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas

1995 · Jeff M. Michalski, Ranjan K. Sur, et al. · International Journal of Radiation Oncology*Biology*Physics · 48

Oral Sucralfate in Acute Radiation Oesophagitis

1994 · Ranjan K. Sur, Rakesh Kochhar, et al. · Acta Oncologica · 48

PDF

Changes in target volume during radiotherapy treatment of invasive bladder carcinoma

1993 · R.K. Sur, J. Clinkard, et al. · Clinical Oncology · 46

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α

2023 · Olga‐Demetra Biziotis, Evangelia Evelyn Tsakiridis, et al. · Molecular Oncology · 41

PDF

Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency

2002 · Subir Nag, Michael Dally, et al. · Radiotherapy and Oncology · 30

Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy

1996 · Monalisa Sur, Ranjan Sur, et al. · Cancer · 30

PDF

External Beam Radiotherapy: A Treatment Option for Massive Haemoptysis Caused by Mycetoma

2002 · Conrad Falkson, Ranjan Sur, et al. · Clinical Oncology · 28

Von recklinghausen's disease associated with a primary malignant schwannoma of the breast

1995 · Simon Malas, Hedley E. Krawitz, et al. · Journal of Surgical Oncology · 28

Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: A case control study

2006 · A Berrington de González, MI Urban, et al. · Infectious Agents and Cancer · 25

PDF

Primary Lymphoma of the Bones of the Foot: Management of Two Cases

1991 · Deepinder Pal Singh, Mandeep Singh Dhillon, et al. · Foot & Ankle · 21

Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy

2008 · Theodoros Tsakiridis, Jean-Claude Cutz, et al. · Journal of Thoracic Oncology · 18

PDF

Surface mold brachytherapy for nonmelanoma skin cancer: Canadian patterns of practice

2014 · Jim N. Rose, Pierre-Yves McLaughlin, et al. · Practical Radiation Oncology · 17

Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone

2004 · R. Sur, B. Donde, et al. · International Journal of Radiation Oncology*Biology*Physics · 16

PDF

Works count: 95

Citation count: 9,086

H-index: 21

I10-index: 34